Project Leadership

James Mulshine, MD, is Professor, Internal Medicine, Rush Medical College. Previously Dr. Mulshine held positions at the National Cancer Institute (NCI), the Division of Cancer Prevention and Control, and the NCI-Navy Medical Oncology Branch. He is an internationally regarded expert in lung cancer.

His research interests include clinical trials in non-small cell lung cancer, tumor immunology (diagnostic or therapeutic applications of monoclonal antibodies); growth factor effects in human lung cancer; information systems; early cancer detection and cancer intervention research, and research facility design and construction.

The recipient of numerous honor and academic awards, Dr. Rush serves on the editorial board or as a reviewer for a number of academic publications, and has authored several hundred articles and books chapters.

Over the course of his career, Dr. Mulshine has chaired, co-chaired, and served as a member of numerous committees, evaluation groups, workshops, and meeting sessions. Most recently, in 2016 Dr. Rush served on the Organizing Committee for the AAMC GRAND Meeting, in Washington, D.C.; and as co-chair of the 17th World Conference on Lung Cancer (WCLC 2016), CT Screening Workshop in Vienna, Austria. He is also a member of the National Photonic Initiative National Technology Road Map Committee.

Dr. Rush received his MD degree from Loyola Stritch School of Medicine.

James Mulshine, MD, is Professor, Internal Medicine, Rush Medical College. Previously Dr. Mulshine held positions at the National Cancer Institute (NCI), the Division of Cancer Prevention and Control, and the NCI-Navy Medical Oncology Branch. He is an internationally regarded expert in lung cancer.

His research interests include clinical trials in non-small cell lung cancer, tumor immunology (diagnostic or therapeutic applications of monoclonal antibodies); growth factor effects in human lung cancer; information systems; early cancer detection and cancer intervention research, and research facility design and construction.

The recipient of numerous honor and academic awards, Dr. Rush serves on the editorial board or as a reviewer for a number of academic publications, and has authored several hundred articles and books chapters.

Over the course of his career, Dr. Mulshine has chaired, co-chaired, and served as a member of numerous committees, evaluation groups, workshops, and meeting sessions. Most recently, in 2016 Dr. Rush served on the Organizing Committee for the AAMC GRAND Meeting, in Washington, D.C.; and as co-chair of the 17th World Conference on Lung Cancer (WCLC 2016), CT Screening Workshop in Vienna, Austria. He is also a member of the National Photonic Initiative National Technology Road Map Committee.

Dr. Rush received his MD degree from Loyola Stritch School of Medicine.

Thomas Asfeldt, MBA, RN, BAN, served as director, Outpatient Cancer Services and Radiation Oncology for Sanford USD Medical Center in Sioux Falls and administrative director for Sanford Health Cancer Center in Worthington, MN. In this role, he was an active leader in integrating and standardizing operations between the radiation oncology services in Sioux Falls and Worthington, and developing rational standards in collaboration with all radiation oncology sites in Sanford Health. He held administrative responsibility for Cancer Program Accreditation by the Commission on Cancer and for the Sanford USD Medical Center Cancer Committee.

Mr. Asfeldt served as the Co-PI, NCI Community Cancer Centers Program (NCCCP) from inception of the NCCCP in 2007 through close of the program in 2014, and was responsible for oversight of all aspects of the NCCCP contract including meeting deliverables and managing contract compliance, administration, and finances.

Prior to joining Sanford in 2005, Thomas worked in Research Triangle Park, N.C., in the biotechnology industry performing program development, client relations, regulatory oversight and hands-on research. He also has extensive experience in the organ procurement industry, coronary intensive care management, and bedside nursing critical care.

Thomas received a Bachelor of Arts Degree in Nursing, with minors in Biology and Chemistry from Concordia College in Moorhead, Minnesota, and a Master of Business Administration with Honors from Regis University in Denver, Colorado.

James Mulshine, MD, is Professor, Internal Medicine, Rush Medical College. Previously Dr. Mulshine held positions at the National Cancer Institute (NCI), the Division of Cancer Prevention and Control, and the NCI-Navy Medical Oncology Branch. He is an internationally regarded expert in lung cancer.

His research interests include clinical trials in non-small cell lung cancer, tumor immunology (diagnostic or therapeutic applications of monoclonal antibodies); growth factor effects in human lung cancer; information systems; early cancer detection and cancer intervention research, and research facility design and construction.

The recipient of numerous honor and academic awards, Dr. Rush serves on the editorial board or as a reviewer for a number of academic publications, and has authored several hundred articles and books chapters.

Over the course of his career, Dr. Mulshine has chaired, co-chaired, and served as a member of numerous committees, evaluation groups, workshops, and meeting sessions. Most recently, in 2016 Dr. Rush served on the Organizing Committee for the AAMC GRAND Meeting, in Washington, D.C.; and as co-chair of the 17th World Conference on Lung Cancer (WCLC 2016), CT Screening Workshop in Vienna, Austria. He is also a member of the National Photonic Initiative National Technology Road Map Committee.

Dr. Rush received his MD degree from Loyola Stritch School of Medicine.

Raymond Uyiosa Osarogiagbon, MD, FACP, is an active practicing hematologist/medical oncologist at the Baptist Cancer Center in Memphis, Tennessee, an American College of Surgeons Commission on Cancer (CoC)-accredited Comprehensive Community Cancer Center. He serves as Director of the Thoracic Oncology Research Group and the Multidisciplinary Thoracic Oncology Program at the Baptist Cancer Center. Additionally, he is Research Professor at the University of Memphis School of Public Health in Memphis, and a member of the Vanderbilt Ingram Cancer Center in Nashville, Tennessee.

His research focuses on improving healthcare systems, including examination of oncology care delivery models, quantifying the relative survival impact of determinants of quality care in thoracic oncology, and improving the quality of surgical resection and pathologic staging of lung cancer. Current research support includes R01 funding from the National Cancer Institute (NCI) and the Patient-Centered Outcomes Research Institute (PCORI). He is also the Principal Investigator of the Baptist Cancer Center/Mid-South Minority-Underserved National Cancer Institute Community Oncology Research Program (NCORP).

Dr. Osarogiagbon is a member of the Alpha Omega Alpha Honor Medical Society (AOA), the American Society of Clinical Oncology (ASCO) Workforce Advisory Group, the National Institutes of Health’s Health Services Organization and Delivery (HSOD) Study Section, and the Board of Directors of the Bonnie J. Addario Lung Cancer Foundation’s Center of Excellence Program. He is also on the editorial boards of the journals Translational Lung Cancer Research and Journal of Thoracic Diseases, as well as the Chairman-Elect of the International Association for the Study of Lung Cancer (IASLC) Membership Committee.

He received his medical degree from the University of Ibadan, Nigeria, and completed Internal Medicine Residency training at Texas Tech University Health Sciences Center in and a Fellowship in Hematology and Medical Oncology at the University of Minnesota.

James Mulshine, MD, is Professor, Internal Medicine, Rush Medical College. Previously Dr. Mulshine held positions at the National Cancer Institute (NCI), the Division of Cancer Prevention and Control, and the NCI-Navy Medical Oncology Branch. He is an internationally regarded expert in lung cancer.

His research interests include clinical trials in non-small cell lung cancer, tumor immunology (diagnostic or therapeutic applications of monoclonal antibodies); growth factor effects in human lung cancer; information systems; early cancer detection and cancer intervention research, and research facility design and construction.

The recipient of numerous honor and academic awards, Dr. Rush serves on the editorial board or as a reviewer for a number of academic publications, and has authored several hundred articles and books chapters.

Over the course of his career, Dr. Mulshine has chaired, co-chaired, and served as a member of numerous committees, evaluation groups, workshops, and meeting sessions. Most recently, in 2016 Dr. Rush served on the Organizing Committee for the AAMC GRAND Meeting, in Washington, D.C.; and as co-chair of the 17th World Conference on Lung Cancer (WCLC 2016), CT Screening Workshop in Vienna, Austria. He is also a member of the National Photonic Initiative National Technology Road Map Committee.

Dr. Rush received his MD degree from Loyola Stritch School of Medicine.